A POTENTIAL new treatment for type-1 diabetes will be discussed at a talk tonight at the ANU.
Guest speaker Dr Charmaine Simeonovic will discuss a discovery she made with Prof Christopher Parish and their research team at The John Curtin School of Medical Research that is now the basis of drugs being developed for patients with type 1 diabetes that will protect the body’s insulin producing cells from damage.
The team, part of the ANU College of Medicine, Biology and Environment, has identified a previously unknown process which caused the destruction of the insulin-producing beta cells in the pancreas.
The researchers found that the insulin-producing cells need a complex sugar, heparan sulphate, for their survival.
Dr Simeonovic will explain how this remarkable discovery was made and the impact it has for the future treatment of type 1 diabetes.
This will be the first in a series of monthly JCSMR Director’s Health Through Discovery Public Lectures.
Lecture – type 1 diabetes – Prospects for a new therapy, 5.30pm – 6.30pm, Monday May 28 at the Finkel Lecture Theatre, The John Curtin School of Medical Research, Building 131 Garran Road, ANU
Who can be trusted?
In a world of spin and confusion, there’s never been a more important time to support independent journalism in Canberra.
If you trust our work online and want to enforce the power of independent voices, I invite you to make a small contribution.
Every dollar of support is invested back into our journalism to help keep citynews.com.au strong and free.
Thank you,
Ian Meikle, editor
Leave a Reply